Balkhed W, Bergram M, Iredahl F, Holmberg M, Edin C, Carlhäll C-J, Ebbers T, Henriksson P, Simonsson C, Rådholm K, Cedersund G, Forsgren M F, Leinhard D O, Jönsson C, Lundberg P, Kechagias S, Dahlström N, Nasr P, Ekstedt M, (2025) Evaluating the prevalence and severity of metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus in primary care, Journal of Internal Medicine, https://doi.org/10.1111/joim.20103
Publication
Tirzepatide and muscle composition changes in people with type 2 diabetes: A post- hoc analysis from a randomised, open-label, parallel-group, phase 3 trial (SURPASS-3 MRI)
Sattar N, Neeland J I, Leinhard D O, Landó F L, Bray R, Linge J, Rodriguez A, (2025) Tirzepatide and muscle composition changes in people with type 2 diabetes: A post- hoc analysis from a randomised, open-label, parallel-group, phase 3 trial (SURPASS-3 MRI), The Lancet Diabetes and Endocrinology, https://doi.org/10.1016/S2213-8587(25)00027-0
Relationship Between Quantitative Magnetic Resonance Imaging Measures and Functional Changes in Patients With Duchenne Muscular Dystrophy
Sherlock P S, McCrady A, Palmer J, Aghamolaey H, Ahlgren A, Widholm P, Dahlqvist Leinhard O, Karlsson M, (2024) Relationship Between Quantitative Magnetic Resonance Imaging Measures and Functional Changes in Patients With Duchenne Muscular Dystrophy, Muscle & Nerve; https://doi.org/10.1002/mus.28321
Longitudinal changes in regional fat and muscle composition and cardiometabolic biomarkers over 5 years of hormone therapy in transgender individuals
Lundberg R T, Tryfonos A, Eriksson MJ L, Rundqvist H, Rullman E, Holmberg M, Maqdasy S, Linge J, Leinhard D O, Arver S, Andersson P D, Wiik A, Gustafsson T, (2024), Longitudinal changes in regional fat and muscle composition and cardiometabolic biomarkers over 5 years of hormone therapy in transgender individuals, Journal of Internal Medicine, https://doi.org/10.1111/joim.20039
Muscle Mass and Glucagon-Like Peptide-1 Receptor Agonists: Adaptive or Maladaptive Response to Weight Loss?
Linge J, Birkenfeld L A, Neeland J I, (2024) Muscle Mass and Glucagon-Like Peptide-1 Receptor Agonists: Adaptive or Maladaptive Response to Weight Loss?, Circulation-AHA, https://doi.org/10.1161/CIRCULATIONAHA.124.067676
Poor muscle health and cardiometabolic risks associated with antidepressant treatment
Andersson P, Linge J, Gurholt TP, Sønderby IE, Hindley G, Andreassen OA, Dahlqvist Leinhard O, (2024) Poor muscle health and cardiometabolic risks associated with antidepressant treatment, Obesity, https://doi.org/10.1002/oby.24085